[1]
Cosman F,de Beur SJ,LeBoff MS,Lewiecki EM,Tanner B,Randall S,Lindsay R, Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2014 Oct; [PubMed PMID: 25182228]
[2]
Chesnut CH 3rd,Silverman S,Andriano K,Genant H,Gimona A,Harris S,Kiel D,LeBoff M,Maricic M,Miller P,Moniz C,Peacock M,Richardson P,Watts N,Baylink D, A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. The American journal of medicine. 2000 Sep; [PubMed PMID: 10996576]
[3]
Binkley N,Bolognese M,Sidorowicz-Bialynicka A,Vally T,Trout R,Miller C,Buben CE,Gilligan JP,Krause DS, A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2012 Aug; [PubMed PMID: 22437792]
[4]
Downs RW Jr,Bell NH,Ettinger MP,Walsh BW,Favus MJ,Mako B,Wang L,Smith ME,Gormley GJ,Melton ME, Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women. The Journal of clinical endocrinology and metabolism. 2000 May; [PubMed PMID: 10843152]
[5]
Muñoz-Torres M,Alonso G,Raya MP, Calcitonin therapy in osteoporosis. Treatments in endocrinology. 2004; [PubMed PMID: 15743107]
[6]
Knopp-Sihota JA,Newburn-Cook CV,Homik J,Cummings GG,Voaklander D, Calcitonin for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fractures: a systematic review and meta-analysis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2012 Jan; [PubMed PMID: 21660557]
[7]
Camacho PM,Petak SM,Binkley N,Clarke BL,Harris ST,Hurley DL,Kleerekoper M,Lewiecki EM,Miller PD,Narula HS,Pessah-Pollack R,Tangpricha V,Wimalawansa SJ,Watts NB, AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS - 2016--EXECUTIVE SUMMARY. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2016 Sep; [PubMed PMID: 27643923]
[8]
Singer FR, Clinical efficacy of salmon calcitonin in Paget's disease of bone. Calcified tissue international. 1991; [PubMed PMID: 1933617]
[9]
Drake MT,Clarke BL,Khosla S, Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clinic proceedings. 2008 Sep; [PubMed PMID: 18775204]
[10]
Wootton R,Reeve J,Spellacy E,Tellez-Yudilevich M, Skeletal blood flow in Paget's disease of bone and its response to calcitonin therapy. Clinical science and molecular medicine. 1978 Jan; [PubMed PMID: 620495]
[11]
Singer FR,Fredericks RS,Minkin C, Salmon calcitonin therapy for Paget's disease of bone. The problem of acquired clinical resistance. Arthritis and rheumatism. 1980 Oct; [PubMed PMID: 7000081]
[13]
Luboshitzky R,Bar-Shalom R, [Calcitonin nasal spray for Paget's disease of the bone]. Harefuah. 1995 Mar 15; [PubMed PMID: 7750816]
[14]
Hosking DJ,Cowley A,Bucknall CA, Rehydration in the treatment of severe hypercalcaemia. The Quarterly journal of medicine. 1981 Autumn; [PubMed PMID: 7342172]
[15]
Wisneski LA, Salmon calcitonin in the acute management of hypercalcemia. Calcified tissue international. 1990; [PubMed PMID: 2137363]
[16]
Bilezikian JP, Clinical review 51: Management of hypercalcemia. The Journal of clinical endocrinology and metabolism. 1993 Dec; [PubMed PMID: 8263125]
[17]
Nilsson O,Almqvist S,Karlberg BE, Salmon calcitonin in the acute treatment of moderate and severe hypercalcemia in man. Acta medica Scandinavica. 1978; [PubMed PMID: 358762]
[19]
Masi L,Brandi ML, Calcitonin and calcitonin receptors. Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases. 2007 May; [PubMed PMID: 22461211]
[20]
Felsenfeld AJ,Levine BS, Calcitonin, the forgotten hormone: does it deserve to be forgotten? Clinical kidney journal. 2015 Apr [PubMed PMID: 25815174]
[21]
Niall HD,Keutmann HT,Copp DH,Potts JT Jr, Amino acid sequence of salmon ultimobranchial calcitonin. Proceedings of the National Academy of Sciences of the United States of America. 1969 Oct; [PubMed PMID: 5261048]
[22]
Andreotti G,Méndez BL,Amodeo P,Morelli MA,Nakamuta H,Motta A, Structural determinants of salmon calcitonin bioactivity: the role of the Leu-based amphipathic alpha-helix. The Journal of biological chemistry. 2006 Aug 25; [PubMed PMID: 16766525]
[23]
Nicholson GC,Moseley JM,Sexton PM,Mendelsohn FA,Martin TJ, Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. The Journal of clinical investigation. 1986 Aug; [PubMed PMID: 3016026]
[24]
Carstens JH Jr,Feinblatt JD, Future horizons for calcitonin: a U.S. perspective. Calcified tissue international. 1991; [PubMed PMID: 1933616]
[25]
Overgaard K,Agnusdei D,Hansen MA,Maioli E,Christiansen C,Gennari C, Dose-response bioactivity and bioavailability of salmon calcitonin in premenopausal and postmenopausal women. The Journal of clinical endocrinology and metabolism. 1991 Feb; [PubMed PMID: 1846873]
[26]
Reginster JY,Franchimont P, Side effects of synthetic salmon calcitonin given by intranasal spray compared with intramuscular injection. Clinical and experimental rheumatology. 1985 Apr-Jun; [PubMed PMID: 2410171]
[27]
Latif A,Gastelum AA,Farhan K,Jagadesh S,Mutnuri S, Treatment approach for primary hyperparathyroidism in pregnancy. Proceedings (Baylor University. Medical Center). 2020 Oct 28 [PubMed PMID: 33456198]
[28]
Peña-Rodríguez ZA,Haro-García M,Benito-Navarro JR, Nasal osteoma and inhaled salmon calcitonin: Coincidence or consequence? Acta otorrinolaringologica espanola. 2017 Nov - Dec [PubMed PMID: 28069111]
[29]
Overman RA,Borse M,Gourlay ML, Salmon calcitonin use and associated cancer risk. The Annals of pharmacotherapy. 2013 Dec; [PubMed PMID: 24259626]
[30]
Ishii J,Katayama S,Itabashi A,Takahama M,Kawazu S, Salmon calcitonin induces pituitary tumor in rats. Endocrinologia japonica. 1991 Dec; [PubMed PMID: 1823038]
[31]
Sondergaard BC,Catala-Lehnen P,Huebner AK,Bay-Jensen AC,Schinke T,Henriksen K,Schilling S,Haberland M,Nielsen RH,Amling M,Karsdal MA, Mice over-expressing salmon calcitonin have strongly attenuated osteoarthritic histopathological changes after destabilization of the medial meniscus. Osteoarthritis and cartilage. 2012 Feb; [PubMed PMID: 22122987]
[32]
Wells G,Chernoff J,Gilligan JP,Krause DS, Does salmon calcitonin cause cancer? A review and meta-analysis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2016 Jan; [PubMed PMID: 26438308]
[33]
Tanaka S,Yoshida A,Kono S,Ito M, Effectiveness of monotherapy and combined therapy with calcitonin and minodronic acid hydrate, a bisphosphonate, for early treatment in patients with new vertebral fractures: An open-label, randomized, parallel-group study. Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association. 2017 May; [PubMed PMID: 28108224]